We are live on ! Find out more
TPTX

Turning Point Therapeutics, Inc. Common Stock
TPTX

Delisted

TPTX was delisted on the 16th of August, 2022.

Back to rankings

70 hedge funds and large institutions have $742M invested in Turning Point Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 70 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
+70
Holders Change %
–
% of All Funds
1.52%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.07%
New
70
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$111M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$106M
3
O
OrbiMed
New York
+$91.6M
4
FCMI
Foresite Capital Management IV
California
+$65.3M
5
VP
venBio Partners
California
+$47.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
51
Barclays
United Kingdom
$174K +$153K +4,281 New
AIG
52
American International Group
New York
$172K +$151K +4,223 New
Bank of America
53
Bank of America
North Carolina
$110K +$96.7K +2,710 New
CSS
54
Cubist Systematic Strategies
Connecticut
$90K +$79K +2,215 New
UBS Group
55
UBS Group
Switzerland
$85K +$74.6K +2,092 New
Citigroup
56
Citigroup
New York
$75K +$66.1K +1,852 New
SO
57
STRS Ohio
Ohio
$73K +$64.2K +1,800 New
Wells Fargo
58
Wells Fargo
California
$72K +$63.6K +1,782 New
JP Morgan Chase
59
JP Morgan Chase
New York
$71K +$65.1K +1,824 New
Legal & General Group
60
Legal & General Group
United Kingdom
$45K +$39.5K +1,106 New
MLICM
61
Metropolitan Life Insurance Company (MetLife)
New York
$28.2K +$24.8K +694 New
TRCT
62
Tower Research Capital (TRC)
New York
$25K +$21.6K +606 New
AIP
63
Ameritas Investment Partners
Nebraska
$24K +$20.9K +586 New
Bank of Montreal
64
Bank of Montreal
Ontario, Canada
$23K +$19.8K +554 New
CCA
65
Catalyst Capital Advisors
New York
$12K +$10.5K +295 New
BNP Paribas Financial Markets
66
BNP Paribas Financial Markets
France
$5.78K +$5.07K +142 New
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$5K +$4K +112 New
Morgan Stanley
68
Morgan Stanley
New York
$5K +$4.1K +115 New
PHK
69
Point72 Hong Kong
Hong Kong
$1K +$1.03K +29 New
Carson Wealth (CWM LLC)
70
Carson Wealth (CWM LLC)
Nebraska
– +$143 +4 New
1 2
3

TPTX Hedge Fund Activity: Q2 2019 in Review

70 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Turning Point Therapeutics, Inc. Common Stock (TPTX) for Q2 2019, worth a combined $742M.

Buyers outnumbered sellers: 70 funds opened new TPTX positions and 0 closed out — a net gain of 70 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $111M.

  • 70 institutional investors held Turning Point Therapeutics, Inc. Common Stock (TPTX) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $742M of Turning Point Therapeutics, Inc. Common Stock stock for Q2 2019.
  • 70 funds opened new Turning Point Therapeutics, Inc. Common Stock positions in Q2 2019 and 0 closed out, a net change of +70 holders.
  • The largest Turning Point Therapeutics, Inc. Common Stock buyer in Q2 2019 was Cormorant Asset Management, an estimated $111M added.

Based on aggregated 13F filings for Q2 2019.